Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Zaparackas and Knepper LTD
Country
Ownership
Private
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β
Phase 2
Not yet recruiting
Conditions
Cognitive Decline
Alzheimer Disease
Mild Cognitive Impairment
Interventions
Drug: Resveratrol, Quercetin, and Curcumin (RQC)
Drug: Curcumin
Subscribe
First Posted Date
2024-06-24
Last Posted Date
2024-06-26
Lead Sponsor
Zaparackas and Knepper LTD
Target Recruit Count
200
Registration Number
NCT06470061
Locations
🇺🇸
Zaparackas & Knepper Ltd., Chicago, Illinois, United States
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy